Notes on Hallucinations, Illusions, Delusions; Anxiety; Major Depression and Bipolar Disorder

Hallucinations, Illusions, Delusions

  • Hallucinations

    • Definition: sensory experiences without any external stimulus or real-world trigger; they feel real to the person

    • Modalities mentioned:

    • Visual hallucinations: Seeing persons or things that are not there

    • Olfactory hallucinations: Smelling odors that are not present

    • Gustatory (taste) hallucinations: Tastes not related to what is ingested

    • Tactile (bodily sensations) hallucinations: Feeling insects crawling on the skin when none are present

    • Auditory hallucinations (voices) are common: hearing voices or sounds telling the person to do things when no one is present

    • Clinical note: These are internal sensory experiences not triggered by external stimuli

    • Nursing approach: When a patient reports a hallucination, do not reinforce the hallucination; present reality and help the patient regain orientation to the real environment (e.g., “I don’t see a fire, you are safe here”).

    • Example given: voices in the head telling them to do something; there is no external source

  • Illusions

    • Definition/characteristic: misinterpretation of an actual stimulus or real experience

    • Example: desert heat waves creating the illusion of an oasis nearby, or sunset colors making one think the earth is on fire; magic tricks sometimes illustrate illusions

  • Delusions

    • Definition: false fixed beliefs that are firmly held despite contrary evidence; beliefs are not open to reason

    • Common types:

    • Delusions of persecution: belief that others (e.g., CIA) are monitoring, targeting, or poisoning

    • Delusions of grandeur: inflated sense of self-importance (e.g., reincarnation of Cleopatra, being a famous movie star)

    • Distinction recap: hallucinations have no external stimulus; illusions are misperceptions of real stimuli; delusions are fixed false beliefs about external reality

  • Miscellaneous/garbled content in transcript

    • A line about a “haunted house” and “Halloween hallucinations” appears garbled and unclear; the core concepts are defined above

  • Quick recap statements from transcript

    • Hallucinations: sensory experiences without external stimuli; can be auditory, visual, olfactory, gustatory, or tactile

    • Illusions: misinterpretations of real stimuli

    • Delusions: fixed false beliefs about reality

    • Hallucinations are internal sensory perceptions not aligned with reality; not explained by external stimuli

  • Practical implication for care

    • When patients report hallucinations or delusions, acknowledge feelings without endorsing the false beliefs

    • Maintain safety and provide grounding/reality-oriented interventions as needed

Anxiety

  • General concept

    • Some level of anxiety or stress is normal and serves as motivation to cope and learn

    • Anxiety disorder refers to a longer-lasting, uncomfortable sense of dread

  • Spectrum of severity

    • Mild, moderate, severe, and panic levels

    • Signs/symptoms vary by level

    • Mild signs: slightly elevated heart rate or breathing, minor sweating

    • Panic signs: high blood pressure, very high respiration, agitation, inability to think straight

  • Triggered vs free-floating anxiety

    • Triggered: signals such as test anxiety (Monday morning tests)

    • Free-floating: no identifiable trigger; more prone to severe anxiety or panic; may include a sense of impending doom

  • Theoretical perspectives

    • Psychodynamic/psychoanalytic view (Freud): linked to unresolved early-life issues (oral gratification stage mentioned in transcript as a reference)

    • Biological/neurotransmitter view: imbalance in brain chemistry

    • Role of GABA (gamma-aminobutyric acid): deficits may contribute to anxiety; GABA helps to calm neural activity

  • Neurochemistry and terminology (as mentioned in transcript)

    • GABA: its lack or reduced effectiveness is linked to increased anxiety; reducing GABA activity may heighten anxiety symptoms

  • Medications discussed

    • Benzodiazepines (class of sedative/anxiolytics) and GABA-related agents described as “LAMs and PAMs” in transcript (note: transcript wording appears to be shorthand; typically relates to GABA receptor modulators)

    • SSRIs (selective serotonin reuptake inhibitors): first-line for many anxiety disorders; examples given: citalopram, escitalopram

    • Other mentions: general reference to a variety of medications used to manage anxiety and prevent recurrence

  • Anxiety disorders described

    • Phobias: intense fears of specific things or situations (e.g., fear of going outside, animals, heights)

    • Panic disorder: recurrent panic attacks with physical symptoms (e.g., chest pain, shortness of breath)

    • Generalized Anxiety Disorder (GAD): uncontrollable excessive worry for at least six months

    • Obsessive-Compulsive Disorder (OCD): intrusive thoughts and repetitive rituals intended to reduce anxiety

    • Post-Traumatic Stress Disorder (PTSD): anxiety triggered by past trauma; memories and cues maintain symptoms; triggers may include anniversaries or reminders

  • Risk factors and epidemiology

    • Females diagnosed more often than males

    • Acute medical conditions can increase risk

    • Substance use (alcohol or drugs) can contribute to anxiety

  • Diagnostic approach

    • Thorough clinical history and physical assessment

    • Labs and imaging (labs, X-ray, CT, MRI) to rule out physical causes

    • Psych evaluation by trained professionals

    • Screening tools available (specific tools not named beyond DSM-5 reference)

    • DSM-5 criteria referenced as the framework for diagnosis

  • DSM-5 and diagnosis process (as described in transcript)

    • Diagnosis is based on meeting DSM-5 criteria; mental health providers use DSM-5 to determine if criteria are satisfied

    • The transcript notes that the DSM-5 is used to determine eligibility for a formal diagnosis

  • Prevention and coping strategies

    • Teach effective coping strategies to reduce anxiety

    • Rest, exercise, and good nutrition

    • Visual imagery and breathing techniques

  • Signs and symptoms: variability by person and severity

    • Physical signs: increased heart rate, increased respirations, sweating, stomach upset/nausea

    • Emotional signs: agitation, lack of focus

  • Treatments and interventions

    • Pharmacologic: benzodiazepines (acute relief/appetite for PRN use in panic), SSRIs (e.g., citalopram, escitalopram), and other agents mentioned as options

    • Psychotherapy options: behavioral management, psychotherapy, group therapy, hypnosis, relaxation techniques, visual imagery, breathing exercises

    • Desensitization (systematic desensitization) for phobias: gradual exposure to feared situations or stimuli (e.g., snakes) to build tolerance

    • Psychotherapy approaches emphasize consent and collaboration with the patient

    • Biofeedback: patients learn to regulate physiological responses (heart rate, breathing) with real-time monitoring

    • Open-ended therapeutic communication: avoid closed questions; use prompts like “Tell me more about how you’re feeling” and paraphrase to demonstrate understanding

  • Other nursing interventions

    • Identifying triggers and patterns through patient history

    • Maintaining a calm milieu (environment)

    • Patient safety during severe anxiety/panic states; one-on-one attention and avoiding group settings when unsafe

    • Observing and documenting patient progress, including both positive changes and areas where interventions did or did not work

    • Encourage engagement in appropriate activities and provide support for self-care tasks (ADLs) as needed

    • In severe manic/panic states, prioritize safety over social or group activities

  • Suicidal ideation and monitoring

    • Monitor for suicidal thoughts or self-harm tendencies, especially in severe states

    • Document changes in behavior and feelings, not just negative symptoms

  • Practical nursing notes

    • Positive self-talk guidance for students and patients, recognizing cognitive patterns affecting mood and anxiety

    • Emphasize observational feedback rather than judgmental praise when patients perform simple tasks (e.g., getting dressed, brushing hair)

  • Takeaway on anxiety

    • Anxiety exists on a spectrum; it can be managed with a combination of pharmacologic therapy, psychotherapy, skill-building, and environmental supports

Mood disorders: Major Depression and Bipolar Disorder

  • Overview

    • Major Depression: persistent depressive mood with no episodes of mania; mood is mainly low

    • Bipolar Disorder: fluctuations between depressive lows and manic/hypomanic highs; characterized by mood instability and significant functional impairment

  • Major Depression (DSM-5-style discussion as described)

    • Core features include depressed mood and loss of interest/pleasure (anhedonia); other symptoms impact daily functioning

    • Key symptoms described in transcript:

    • Anhedonia: diminished interest or pleasure in usual activities

    • Weight changes: weight loss or weight gain; appetite changes

    • Sleep disturbances: hypersomnia or insomnia

    • Fatigue and low energy

    • Psychomotor changes: retardation (slowed movements) or agitation

    • Feelings of guilt, worthlessness, or hopelessness

    • Cognitive impact: impaired concentration, memory issues

    • Suicidal ideation or attempts

    • Social withdrawal or isolation

    • Functional impact: difficulty performing ADLs (activities of daily living), neglect of personal care, and reduced functioning at work or home

  • Bipolar Disorder (as described in transcript)

    • Manic/hypomanic features during high phases:

    • Euphoric mood: abnormally elevated and expansive mood

    • Increased energy: decreased need for sleep; hyperactivity

    • Flight of ideas: rapid, racing thoughts with a tangent-filled speech pattern (speaking rapidly, difficult to follow)

    • Grandiosity: inflated self-esteem or belief in special abilities

    • Distractibility: easily drawn to multiple stimuli

    • Risk-taking and impulsive behavior: shopping sprees, oversized purchases, lavish gifts

    • Irritability when others attempt to constrain or moderate behavior

    • Depressive phases (as described):

    • Low mood, anhedonia, fatigue, feelings of guilt or worthlessness

    • Psychomotor retardation during depressive episodes (slower movements)

    • Safety concerns during acute mania

    • Impulsivity and poor judgment can lead to risky or harmful behavior

    • Individuals may threaten safety of themselves or others; staff must ensure safety and limit group exposure during acute mania

  • Diagnostic considerations and tools

    • PHQ-9 for major depression screening: a common tool used in clinical settings; asks about symptoms over the past two weeks; responses guide further assessment

    • DSM-5 criteria referenced: formal diagnoses rely on meeting DSM-5 criteria after detailed history and evaluation

    • Referral to mental health professionals for comprehensive assessment and treatment planning

  • Treatment approaches

    • Major Depression

    • Pharmacologic: Start with SSRIs as first-line treatment; other antidepressants may be used if SSRIs are not effective

    • Mood stabilizers/adjuncts: For bipolar presentations, mood stabilizers are used to stabilize mood (see bipolar section below)

    • Psychotherapy: Individual or group therapy; cognitive-behavioral approaches; target symptoms and coping strategies

    • Electroconvulsive therapy (ECT): Considered for severe or treatment-resistant depression; not a first-line therapy; involves inducing seizures under controlled anesthesia; may cause temporary confusion or muscle soreness; advances can reset neurotransmitter balance in the brain

    • Other mood stabilizers/anticonvulsants: Used in bipolar or mixed presentations (e.g., Lithium, Valproate/Depakote, Carbamazepine, Lamotrigine/Lamictal, Keppra/Levetiracetam)

    • Bipolar Disorder

    • Mood stabilizers: Lithium is a common mood stabilizer used to manage bipolar disorder

    • Anticonvulsants: Valproate (Depakote), Lamotrigine (Lamictal), Carbamazepine; used to stabilize mood during depressive and manic episodes

    • Antidepressants: Used with caution in bipolar disorder due to risk of triggering mania; often combined with mood stabilizers

    • Psychotherapy: Individual or group therapy; cognitive-behavioral approaches; family therapy can be beneficial

    • ECT: Sometimes used in severe depressive episodes or treatment-resistant cases; similar considerations as above

  • Diagnosing and monitoring

    • Diagnosis relies on clinical history, DSM-5 criteria, and comprehensive assessment by mental health professionals

    • PHQ-9 used to screen for depression; further evaluation determines treatment plan

    • Regular lab monitoring when using mood stabilizers or anticonvulsants due to potential side effects or therapeutic ranges

  • Nursing and therapeutic interventions

    • Support with ADLs and daily routines during depressive episodes

    • Observational statements and neutral feedback: avoid judgmental praise; use objective observations (e.g., “I see you came out for breakfast today; your hair looks brushed.”)

    • Encourage engagement in daily activities and self-care as mood improves

    • Observation of progress: document what helped and what didn’t; tailor plans accordingly

    • Safety planning for suicidal thoughts or behaviors; ensure a safe environment and involve family or care team as needed

    • When patient is in manic or panic state, prioritize safety and keep patient away from potentially risky situations; one-on-one support and a calm setting are recommended

  • Etiology and risk factors (connections across mood disorders)

    • Possible causes include grief or unresolved loss, unreconciled anger, or altered interpretation of events

    • Biological factors: neurotransmitter involvement (e.g., serotonin, epinephrine) and potential genetic predisposition

    • These factors contribute to the risk profile and inform treatment strategies

  • Therapeutic relationships and communication in mood disorders

    • Involve patients in treatment planning; obtain consent for psychotherapy or behavior modification strategies

    • Use supportive, non-judgmental language; avoid implying blame for depressive or manic symptoms

    • Emphasize collaborative care and a stable routine to support recovery

  • Break reminder handled in transcript

    • The session indicated a break (11:55) and that content on schizophrenia would follow; notes here focus on hallucinations, anxiety, and mood disorders as presented

Key connections to foundational concepts and real-world relevance

  • Sensory misperceptions (hallucinations, illusions) relate to how the nervous system processes input and how psychiatric conditions can alter perception

  • Anxiety and mood disorders share neurobiological and psychosocial risk factors; coping strategies and safety planning are essential across disorders

  • DSM-5 criteria provide a standardized framework for diagnosis; PHQ-9 is a practical screening tool used in many clinical settings

  • Treatments span pharmacology, psychotherapy, and structured behavioral techniques (e.g., desensitization, biofeedback); evidence supports combination approaches for many patients

  • Ethical considerations include informed consent for psychotherapy and ensuring patient safety; maintaining a calm milieu and using neutral, non-judgmental language supports therapeutic rapport

  • Real-world relevance: recognizing early signs of anxiety and mood disorders, initiating appropriate referrals, and implementing safety planning can significantly impact patient outcomes